These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31364274)

  • 21. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
    Hong SK; Hwang SM; Kim JE; Kim HK
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays.
    Pradella P; Azzarini G; Santarossa L; Caberlotto L; Bardin C; Poz A; D'Aurizio F; Giacomello R
    Clin Chem Lab Med; 2013 Feb; 51(2):379-85. PubMed ID: 23001319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients.
    Moore GW; Culhane AP; Maloney JC; Archer RA; Breen KA; Hunt BJ
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):477-80. PubMed ID: 26656903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey.
    Favaloro EJ; Wong RC
    Pathology; 2009; 41(7):666-75. PubMed ID: 20001347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.
    Devreese KMJ; de Groot PG; de Laat B; Erkan D; Favaloro EJ; Mackie I; Martinuzzo M; Ortel TL; Pengo V; Rand JH; Tripodi A; Wahl D; Cohen H
    J Thromb Haemost; 2020 Nov; 18(11):2828-2839. PubMed ID: 33462974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J; Meijer P; Vermylen J
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and laboratory practice for lupus anticoagulant testing: An International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey.
    Cohen H; Mackie IJ; Devreese KMJ;
    J Thromb Haemost; 2019 Oct; 17(10):1715-1732. PubMed ID: 31271706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2021 Aug; 43(4):771-778. PubMed ID: 33974363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lupus anticoagulant: a multicenter study for a standardized and harmonized reporting.
    Poz A; Pradella P; Azzarini G; Santarossa L; Bardin C; Zardo L; Giacomello R
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):176-84. PubMed ID: 26366826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA).
    Favaloro EJ
    Am J Hematol; 2019 Nov; 94(11):1290-1296. PubMed ID: 31379004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
    Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
    Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis.
    Tripodi A; Cohen H; Devreese KMJ
    J Thromb Haemost; 2020 Jul; 18(7):1569-1575. PubMed ID: 32619349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction.
    Lee Y; Gu JY; Kim HK
    J Thromb Thrombolysis; 2022 Aug; 54(2):318-322. PubMed ID: 35841477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.
    Kanouchi K; Narimatsu H; Ohnuma O; Morikane K; Fukao A
    Int J Hematol; 2017 Aug; 106(2):206-211. PubMed ID: 28390037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography.
    Devreese K; Peerlinck K; Arnout J; Hoylaerts MF
    Thromb Haemost; 2009 Jan; 101(1):185-96. PubMed ID: 19132207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
    Radin M; Sciascia S; Erkan D; Pengo V; Tektonidou MG; Ugarte A; Meroni P; Ji L; Belmont HM; Cohen H; Ramires de Jesús G; Branch DW; Fortin PR; Andreoli L; Petri M; Rodriguez E; Rodriguez-Pinto I; Knight JS; Atsumi T; Willis R; Gonzalez E; Lopez-Pedrera R; Rossi Gandara AP; Borges Gualhardo Vendramini M; Banzato A; Sevim E; Barbhaiya M; Efthymiou M; Mackie I; Bertolaccini ML; Andrade D;
    Semin Arthritis Rheum; 2019 Dec; 49(3):464-468. PubMed ID: 31153708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update.
    Erkan D; Sciascia S; Bertolaccini ML; Cohen H;
    Curr Rheumatol Rep; 2021 May; 23(6):45. PubMed ID: 33932165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.